Total Payments
$76,589
2024 Payments
$24,757
Companies
27
Transactions
214
Medicare Patients
3,843
Medicare Billing
$1.9M
Payment Breakdown by Category
Other$49,990 (65.3%)
Consulting$13,390 (17.5%)
Food & Beverage$8,225 (10.7%)
Travel$4,869 (6.4%)
Education$97.99 (0.1%)
Gifts$17.24 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $27,180 | 6 | 35.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,810 | 5 | 29.8% |
| Consulting Fee | $13,390 | 10 | 17.5% |
| Food and Beverage | $8,225 | 170 | 10.7% |
| Travel and Lodging | $4,869 | 21 | 6.4% |
| Education | $97.99 | 1 | 0.1% |
| Gift | $17.24 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EyePoint Pharmaceuticals US, Inc. | $28,738 | 41 | $0 (2023) |
| Alimera Sciences, Inc. | $28,730 | 33 | $0 (2024) |
| Carl Zeiss Meditec, Inc. | $6,785 | 9 | $0 (2024) |
| Genentech USA, Inc. | $3,813 | 15 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $2,754 | 10 | $0 (2022) |
| Dutch Ophthalmic, USA | $839.68 | 1 | $0 (2024) |
| ABBVIE INC. | $701.42 | 27 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $576.98 | 20 | $0 (2024) |
| Carl Zeiss Meditec USA, Inc. | $562.70 | 4 | $0 (2024) |
| AtriCure, Inc. | $547.28 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24,757 | 50 | Alimera Sciences, Inc. ($22,022) |
| 2023 | $32,651 | 64 | EyePoint Pharmaceuticals US, Inc. ($24,133) |
| 2022 | $10,089 | 47 | Carl Zeiss Meditec, Inc. ($4,538) |
| 2021 | $1,192 | 21 | EyePoint Pharmaceuticals US, Inc. ($300.41) |
| 2020 | $3,803 | 7 | Genentech USA, Inc. ($3,300) |
| 2019 | $1,696 | 10 | Regeneron Pharmaceuticals, Inc. ($1,616) |
| 2018 | $2,237 | 12 | Regeneron Pharmaceuticals, Inc. ($1,055) |
| 2017 | $164.26 | 3 | Novartis Pharmaceuticals Corporation ($124.99) |
All Payment Transactions
214 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $4.57 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/05/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $148.08 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/04/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: EYE CARE | ||||||
| 11/21/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: Ophthalmology | ||||||
| 11/18/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: EYE CARE | ||||||
| 11/16/2024 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Travel and Lodging | In-kind items and services | $839.68 | General |
| Category: Ophthalmology | ||||||
| 10/29/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Ophthalmology | ||||||
| 10/28/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 10/15/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: EYE CARE | ||||||
| 09/30/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 09/25/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: EYE CARE | ||||||
| 09/19/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: EYE CARE | ||||||
| 09/18/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.41 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/05/2024 | Carl Zeiss Meditec, Inc. | CIRRUS 6000 with AngioPlex (Device), CLARUS, FORUM Glaucoma Workplace | Consulting Fee | Cash or cash equivalent | $812.50 | General |
| Category: Optical Tomography | ||||||
| 08/28/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: EYE CARE | ||||||
| 08/21/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: Ophthalmology | ||||||
| 08/14/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Ophthalmology | ||||||
| 07/23/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $30.70 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/10/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: EYE CARE | ||||||
| 06/28/2024 | Bausch & Lomb Americas Inc. | Stellaris (Device) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Ophthalmology | ||||||
| 06/25/2024 | Alimera Sciences, Inc. | ILUVIEN (Drug), YUTIQ | Honoraria | Cash or cash equivalent | $465.00 | General |
| Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid | ||||||
| 06/25/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 06/12/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,294 | 6,395 | $2.4M | $643,889 |
| 2022 | 14 | 1,213 | 3,052 | $3.5M | $667,696 |
| 2021 | 12 | 943 | 2,449 | $2.5M | $475,884 |
| 2020 | 9 | 393 | 606 | $292,974 | $102,371 |
Total Patients
3,843
Total Services
12,502
Medicare Billing
$1.9M
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 106 | 562 | $1.6M | $389,396 | 24.5% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 19 | 3,840 | $168,670 | $109,709 | 65.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 192 | 463 | $182,381 | $41,405 | 22.7% |
| J3590 | Unclassified biologics | Office | 2023 | 41 | 110 | $61,300 | $23,216 | 37.9% |
| 92134 | Imaging of retina | Office | 2023 | 424 | 747 | $108,804 | $21,111 | 19.4% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 15 | 112 | $63,812 | $17,760 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 162 | 180 | $43,675 | $11,453 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 118 | 137 | $63,631 | $10,537 | 16.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $35,050 | $7,109 | 20.3% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 67 | 67 | $29,561 | $4,182 | 14.1% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 35 | 41 | $17,608 | $3,816 | 21.7% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 26 | 47 | $7,395 | $2,714 | 36.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 11 | 11 | $6,380 | $1,011 | 15.8% |
| 92250 | Photography of the retina | Office | 2023 | 17 | 17 | $1,999 | $471.74 | 23.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 77 | 602 | $2.3M | $430,489 | 18.9% |
| J3490 | Unclassified drugs | Office | 2022 | 14 | 44 | $308,000 | $79,988 | 26.0% |
| 67028 | Injection of drug into eye | Office | 2022 | 153 | 490 | $242,710 | $43,655 | 18.0% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2022 | 15 | 168 | $134,568 | $26,439 | 19.6% |
| 92134 | Imaging of retina | Office | 2022 | 365 | 895 | $141,352 | $24,772 | 17.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 147 | 240 | $121,440 | $21,249 | 17.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 128 | 163 | $58,178 | $9,115 | 15.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 92 | 97 | $47,239 | $8,275 | 17.5% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 74 | 88 | $39,160 | $7,506 | 19.2% |
| J3590 | Unclassified biologics | Office | 2022 | 55 | 163 | $52,649 | $7,253 | 13.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $15,792 | $2,706 | 17.1% |
About Dr. Arjun Sood, MD
Dr. Arjun Sood, MD is a Ophthalmology healthcare provider based in Blue Ash, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2013. The National Provider Identifier (NPI) number assigned to this provider is 1487097341.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arjun Sood, MD has received a total of $76,589 in payments from pharmaceutical and medical device companies, with $24,757 received in 2024. These payments were reported across 214 transactions from 27 companies. The most common payment nature is "Honoraria" ($27,180).
As a Medicare-enrolled provider, Sood has provided services to 3,843 Medicare beneficiaries, totaling 12,502 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Blue Ash, OH
- Active Since 04/10/2013
- Last Updated 07/01/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1487097341
Products in Payments
- YUTIQ (Drug) $29,155
- ILUVIEN (Drug) $28,178
- Lucentis (Biological) $3,300
- ARTEVO 800 (Device) $3,023
- OZURDEX (Drug) $1,013
- EVA, combined machine (Device) $839.68
- CIRRUS 6000 with AngioPlex (Device) $812.50
- EYLEA (Biological) $553.33
- AtriCure AtriClip LAA Exclusion System (Device) $547.28
- Vabysmo (Drug) $304.91
- LUMERA 700 (Device) $270.15
- XIPERE (Drug) $172.50
- RETISERT (Drug) $167.63
- Susvimo (Drug) $148.08
- Constellation (Device) $146.09
- NGENUITY (Device) $135.58
- ACTHAR (Biological) $119.55
- Izervay (Drug) $116.84
- DEXYCU (Drug) $116.64
- DEXTENZA (Drug) $101.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Blue Ash
Dr. Lucas Lindsell, M.d., O.d, M.D., O.D
Ophthalmology — Payments: $89,267
Ophthalmology $89,267
James Osher, M.d, M.D
Ophthalmology — Payments: $11,589
Ophthalmology $11,589
Ferdinand Rodriguez Agramonte, M.d, M.D
Ophthalmology — Payments: $6,563
Ophthalmology $6,563
Dr. Andrew Barfell, Md, MD
Ophthalmology — Payments: $4,801
Ophthalmology $4,801
Dr. Kavitha Sivaraman, M.d, M.D
Ophthalmology — Payments: $4,612
Ophthalmology $4,612
Patrick Burchell, M.d, M.D
Ophthalmology — Payments: $3,236
Ophthalmology $3,236